Product Information
Name:CPI-1205
Controlled Product
Brand:Biosynth
Description:CPI-1205 is a novel small molecule that has been shown to have anticancer activity in vitro and in vivo. It inhibits methyltransferases, which are enzymes that transfer methyl groups from one molecule to another. CPI-1205 has been shown to be safe with a favorable safety profile. This drug is currently being studied in phase IB/II clinical trials for the treatment of various cancers, including leukemia, lung cancer, and ovarian cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:518.57 g/mol
Formula:C27H33F3N4O3
Purity:Min. 95%
Technical inquiry about: CPI-1205
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.